[1]
|
Doolan A, Langlois N, Semsarian C. Causes of sudden cardiac death in young Australians. Med J Aust 2004: 180: 110-112
|
[2]
|
Maron BJ. Sudden death in young athletes. N Engl J Med 2003: 349: 1064-1075.
|
[3]
|
Kawahito K, Murata S, Yasu T, Adachi H, Ino T, Saito M, et al. Usefulness of extracorporeal membrane oxygenation for treatment of fulminant myocarditis and circulatory collapse. Am J Cardiol. 1998; 82: 910-911.
|
[4]
|
Kato S, Morimoto S, Hiramitsu S, Nomura M, Ito T, Hishida H. Use of percutaneous cardiopulmonary support of patients with fulminant myocarditis and cardiogenic shock for improving prognosis. Am J Cardiol. 1999; 83: 623-625, A610.
|
[5]
|
Inoue Y, Kaneko H, Yoshizawa Y, Morikawa A. Rescue of a child with fulminant myocarditis using percutaneous cardiopulmonary support. Pediatr Cardiol. 2000; 21: 158-160.
|
[6]
|
Kohno K, Aoyama N, Shimohama T, Yoshida M, Machida Y, Fukuda N, et al. Resuscitation from fulminant myocarditis associated with refractory ventricular fibrillation. Jpn Circ J. 2000; 64: 139-143.
|
[7]
|
Arima M, Kanoh T, Kawano Y, Okazaki S, Oigawa T, Yamagami S, et al. Recurrence of myocarditis presenting as pacing and sensing failure after implantation of a permanent pacemaker at first onset. Jpn Circ J. 2001; 65: 345-348.
|
[8]
|
Izawa A, Kinoshita O, Shiba Y, Takahashi W, Uchikawa S, Imamura H, et al. Percutaneous cardiopulmonary support aids resuscitation from sustained ventricular tachycardia. Circ J. 2003; 67: 1061-1063.
|
[9]
|
Felker GM Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol. 2000; 36: 227-232.
|
[10]
|
Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol. 1991; 18: 1617-1626.
|
[11]
|
Magnani JW, Dec GW. Myocarditis: current trends in diagnosis and treatment. Circulation. 2006; 113: 876-890.
|
[12]
|
Mason JW, O'Connell JB, Herskowitz A, Rose NR, McManus BM, Billingham ME, Moon TE, for The Myocarditis Treatment Trial Investigators. A Clinical Trial of Immunosuppressive Therapy for Myocarditis N Engl J Med 333: 269-275
|
[13]
|
McNamara DM, Rosenblum WD, Janosko KM, Trost MK, Villaneuva FS, Demetris AJ, Murali S, Feldman AM Intravenous Immune Globulin in the Therapy of Myocarditis and Acute Cardiomyopathy Circulation. 1997; 95: 2476-2478
|
[14]
|
McNamara DM, Holubkov R, Starling RC, Dec GW, Loh E, GuillTorre-Amione G, Gass A, Janosko K, Tokarczyk T, Kessler P, Mann DL, Feldman AM. Controlled Trial of Intravenous Immune Globulin in Recent-Onset Dilated Cardiomyopathy Circulation. 2001;103: 2254-2259
|
[15]
|
Shioji K, Matsuura Y, Iwase T, Kitaguchi S, Nakamura H, Yodoi J, et al. Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report. Circ J. 2002; 66: 977-980.
|
[16]
|
Cooper LT Jr. Myocarditis. N Eng J Med 2009; 360: 1526-1538.
|